Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Relation of visceral adiposity to circulating natriuretic peptides in ambulatory individuals.

Cheng S, Fox CS, Larson MG, Massaro JM, McCabe EL, Khan AM, Levy D, Hoffmann U, O'Donnell CJ, Miller KK, Newton-Cheh C, Coviello AD, Bhasin S, Vasan RS, Wang TJ.

Am J Cardiol. 2011 Oct 1;108(7):979-84. doi: 10.1016/j.amjcard.2011.05.033. Epub 2011 Aug 1.

2.

Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile.

Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, Khera A, McGuire DK, Vega GL, de Lemos JA, Turer AT.

J Am Coll Cardiol. 2013 Aug 20;62(8):752-60. doi: 10.1016/j.jacc.2013.03.038. Epub 2013 Apr 16.

3.

Gender differences in the association of visceral and subcutaneous adiposity with adiponectin in African Americans: the Jackson Heart Study.

Bidulescu A, Liu J, Hickson DA, Hairston KG, Fox ER, Arnett DK, Sumner AE, Taylor HA, Gibbons GH.

BMC Cardiovasc Disord. 2013 Feb 22;13:9. doi: 10.1186/1471-2261-13-9.

4.

Association of subcutaneous and visceral adiposity with albuminuria: the Framingham Heart Study.

Foster MC, Hwang SJ, Massaro JM, Hoffmann U, DeBoer IH, Robins SJ, Vasan RS, Fox CS.

Obesity (Silver Spring). 2011 Jun;19(6):1284-9. doi: 10.1038/oby.2010.308. Epub 2010 Dec 23.

5.

Muscle mass, visceral fat, and plasma levels of B-type natriuretic peptide in healthy individuals (from the J-SHIPP Study).

Yamashita T, Kohara K, Tabara Y, Ochi M, Nagai T, Okada Y, Igase M, Miki T.

Am J Cardiol. 2014 Aug 15;114(4):635-40. doi: 10.1016/j.amjcard.2014.05.050. Epub 2014 Jun 6.

PMID:
25001150
6.

Hyperinsulinemia correlates with low levels of plasma B-type natriuretic peptide in Japanese men irrespective of fat distribution.

Nakatsuji H, Kishida K, Funahashi T, Nakagawa T, Shimomura I.

Cardiovasc Diabetol. 2012 Mar 7;11:22. doi: 10.1186/1475-2840-11-22.

7.

Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies.

Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, McCabe EL, Coviello AD, Florez JC, Fox CS, Levy D, Robins SJ, Arora P, Bhasin S, Lam CS, Vasan RS, Melander O, Wang TJ.

J Clin Endocrinol Metab. 2011 Oct;96(10):3242-9. doi: 10.1210/jc.2011-1182. Epub 2011 Aug 17.

8.

Influence of sex and hormone status on circulating natriuretic peptides.

Lam CS, Cheng S, Choong K, Larson MG, Murabito JM, Newton-Cheh C, Bhasin S, McCabe EL, Miller KK, Redfield MM, Vasan RS, Coviello AD, Wang TJ.

J Am Coll Cardiol. 2011 Aug 2;58(6):618-26. doi: 10.1016/j.jacc.2011.03.042.

9.

Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.

Sarullo FM, Gristina T, Brusca I, Serio G, Taormina A, La Chiusa SM, Castello A, Borruso E, Paterna S, Di Pasquale P.

Minerva Cardioangiol. 2007 Apr;55(2):149-55.

PMID:
17342035
10.

Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study.

Pou KM, Massaro JM, Hoffmann U, Vasan RS, Maurovich-Horvat P, Larson MG, Keaney JF Jr, Meigs JB, Lipinska I, Kathiresan S, Murabito JM, O'Donnell CJ, Benjamin EJ, Fox CS.

Circulation. 2007 Sep 11;116(11):1234-41. Epub 2007 Aug 20.

11.

Changes in liraglutide-induced body composition are related to modifications in plasma cardiac natriuretic peptides levels in obese type 2 diabetic patients.

Li CJ, Yu Q, Yu P, Yu TL, Zhang QM, Lu S, Yu DM.

Cardiovasc Diabetol. 2014 Feb 5;13:36. doi: 10.1186/1475-2840-13-36.

12.

N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity.

Fernandes F, Ramires FJ, Buck PC, Almeida IJ, Rabelo R, Dantas SA, Salemi VM, Halpern A, Mady C.

Braz J Med Biol Res. 2007 Feb;40(2):153-8.

13.

Relation of coronary atherosclerosis determined by electron beam computed tomography and plasma levels of n-terminal pro-brain natriuretic peptide in a multiethnic population-based sample (the Dallas Heart Study).

Abdullah SM, Khera A, Das SR, Stanek HG, Canham RM, Chung AK, Morrow DA, Drazner MH, McGuire DK, de Lemos JA.

Am J Cardiol. 2005 Nov 1;96(9):1284-9. Epub 2005 Sep 9.

PMID:
16253599
14.

Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu CY, Vasan RS, Murabito JM, Meigs JB, Cupples LA, D'Agostino RB Sr, O'Donnell CJ.

Circulation. 2007 Jul 3;116(1):39-48. Epub 2007 Jun 18.

15.

Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia.

Sabatine MS, Morrow DA, de Lemos JA, Omland T, Desai MY, Tanasijevic M, Hall C, McCabe CH, Braunwald E.

J Am Coll Cardiol. 2004 Nov 16;44(10):1988-95.

16.

Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.

Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, van den Meiracker AH, Boersma E, Schinkel AF, Kertai MD, van Sambeek MR, Poldermans D.

Am J Cardiol. 2006 Jul 1;98(1):111-5. Epub 2006 May 6.

PMID:
16784932
17.

Association of cardiac and renal function with extreme N-terminal fragment pro-B-type natriuretic peptide levels in elderly patients.

Cui H, Huo G, Liu L, Fan L, Ye P, Cao J, Bai Y, Wang F, Hu Y.

BMC Cardiovasc Disord. 2012 Jul 26;12:57. doi: 10.1186/1471-2261-12-57.

18.

Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction.

Costello-Boerrigter LC, Boerrigter G, Redfield MM, Rodeheffer RJ, Urban LH, Mahoney DW, Jacobsen SJ, Heublein DM, Burnett JC Jr.

J Am Coll Cardiol. 2006 Jan 17;47(2):345-53. Epub 2006 Jan 4.

19.

[Factors associated plasma B type natriuretic peptide and N-terminal pro-B-type natriuretic peptide levels].

Chen Y, Yao CL, Shimada T.

Zhonghua Xin Xue Guan Bing Za Zhi. 2008 Sep;36(9):825-30. Chinese.

PMID:
19102867
20.

Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.

Potocki M, Mair J, Weber M, Hamm C, Burkard T, Hiemetzberger R, Peters K, Jander N, Cron TA, Hess N, Hoffmann A, Gekeler H, Gohlke-Bärwolf C, Buser P, Mueller C.

Am J Cardiol. 2009 Aug 15;104(4):559-64. doi: 10.1016/j.amjcard.2009.04.023. Epub 2009 Jun 18.

PMID:
19660612

Supplemental Content

Support Center